Navigation Links
Neutrogena(R) Partnership For Skin Health Taps Malin Akerman to Educate About Skin Cancer Detection
Date:6/25/2008

Viral video communicates the importance of skin cancer self-examination

LOS ANGELES, June 25 /PRNewswire/ -- The Neutrogena(R) Partnership for Skin Health, a public service initiative that partners with organizations and individuals to educate, promote advancements and explore solutions for skin health, has tapped actress Malin Akerman to educate consumers in a viral video about self-examination for skin cancer detection. As the #1 dermatologist recommended skincare brand and the leader in sun protection technology, Neutrogena(R) is committed to educating and empowering individuals about the importance of self-examinations to detect skin cancer in its earliest and most treatable stage.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080625/NYW074)

The viral video, starring Akerman, shows a couple performing skin self checks to demonstrate how easy it is to engage with a loved one for early detection of skin cancer. The goal of the video is to empower consumers to take control of their health and encourage both men and women to check themselves for skin cancer.

"The viral video shows how skin examinations can be fun, while communicating the seriousness of the skin cancer message," said Jim Colleran, President, Neutrogena(R) Corporation. "This video is meant to create buzz, spark conversation and serve as a 'wake-up call' to consumers about the importance of self-examination in detecting skin cancer."

"This video and message is something I have a passion for because I understand the importance of checking your skin for suspicious moles," says Malin Akerman. "I recently had a suspicious mole removed from my face; I noticed it was changing shape and asked my dermatologist to examine it. I was one of the luckier ones because it wasn't cancerous."

Skin cancer is the most common form of cancer in the US; one in five Americans will develop skin cancer
'/>"/>

SOURCE Neutrogena(R)
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Neutrogena(R) Dermatologics Introduces skin iD(TM), the First Personalized Acne Solution
2. Update: Oscar-Nominated Actress Signs on as Neutrogena(R) Brand Ambassador
3. Oscar-Nominated Actress Signs on as Neutrogena(R) Brand Ambassador
4. Abbott and Partnership for a Drug-Free America Launch Not In My House to Help Parents Secure Their Homes from Teen Prescription Drug Misuse and Abuse
5. FHS Corp Signs Partnership Agreement With Concuity
6. Chiltern and EPS INTERNATIONAL Enter Into a Global Partnership
7. Media Advisory - Minister of Health, the Honorable Tony Clement to announce partnership between Canadas Cancer Stem Cell Consortium and the California Institute for Regenerative Medicine for international collaboration to advance cancer stem cell researc
8. Partnership Releases 20th Annual Survey of Parental Attitudes Toward Drug Use
9. R-Squared and MDMA Announce Partnership
10. SUA Insurance Company Announces Partnership With American Safety Indemnity Company
11. Alternative Extends Partnership With Elizabeth Glaser Pediatric AIDS Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Vegas Hotel Escapes, the ... announce all new vacation packages for the upcoming ... Las Vegas for this patriotic holiday will be ... to VegasHotelEscapes.com's new special pricing available on VegasHotelEscapes.com's ... it guarantees the lowest prices possible on vacation ...
(Date:5/23/2013)... New Jersey (PRWEB) May 23, 2013 ... Americans suffering from irritable bowel syndrome (IBS), the food ... on your holiday fun. , “While hot dogs and ... plate during the warm weather months, IBS sufferers often ... says Deborah Sokol, MD, a gastroenterologist with Lourdes Medical ...
(Date:5/23/2013)... 23, 2013 Onlinefitnessreview.com recently published a ... to determine what makes this diet work and how ... highlights three main components of the program: eliminating foods ... mindset and the personal motivation that is needed to ... days to keep the metabolism rate in top gear. ...
(Date:5/23/2013)... Mann HealthDay Reporter , , THURSDAY, May 23 ... take to help treat hip and knee osteoarthritis may ... for developing glaucoma, a small new study of older ... an increase of intraocular pressure (IOP) or pressure inside ... leading causes of blindness. In the ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Memorial Day ... , Chaplains have been a part of the U.S. ... Day, like those preceding it, these men and women ... the United States of America. As veterans transition ... their migration to the workplace chaplaincy world. , ...
Breaking Medicine News(10 mins):Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 2Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 3Health News:Onlinefitnessreview.com Publishes 7 Day Belly Blast Diet Review 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 3Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 2Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 3
... affect psychological well-being, , FRIDAY, Sept. 25 (HealthDay News) -- ... lose IQ points. , The good news is that it ... at least one expert believes that part of the reason ... in the United States and elsewhere. , That,s the view ...
... Life ... with one of its Northwest Division President,s Awards on Monday, Sept. 21. , ... Kirkland, WA (PRWEB) September 25, 2009 -- ... Care Center of Kirkland , with one of its Northwest Division President,s Awards on Monday, ...
... ... portable oxygen machine from Invacare with an amazing 1.8 liters per minute ... oxygen output. Now, oxygen therapy patients requiring large doses of oxygen can ... mobility and freedom. This new portable concentrator is now available for online ...
... researchers say , THURSDAY, Sept. 24 (HealthDay News) -- ... with carpal tunnel syndrome who don,t have severe nerve ... included 44 patients who had surgery and 52 patients ... ultrasound. A year after treatment, the patients, hand function ...
... CA SEPTEMER 24, 2009 Results from a ... combination of giving patients clopidogrel, a blood thinner commonly ... such as omeprazole, known as proton pump inhibitors (PPIs), ... studies had suggested. The results were presented at the ...
... BEDFORD, Mass., Sept. 24 ... HOLX ), a leading developer, manufacturer and supplier ... dedicated to serving the healthcare needs of women, today ... Clinical Excellence (NICE), in its updated guidance for hysteroscopic ...
Cached Medicine News:Health News:Spanking May Lower Kids' IQs 2Health News:Spanking May Lower Kids' IQs 3Health News:Local Nursing Home Leader Receives Life Care's Northwest Division President's Award 2Health News:New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 2Health News:New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 3Health News:New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 4Health News:New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 5Health News:Surgery Best for Carpal Tunnel Syndrome 2Health News:Surgery Best for Carpal Tunnel Syndrome 3Health News:Cogent trial shows lack of adverse interaction between clopidogrel and stomach medicine 2Health News:New U.K. NICE Guidance Supports Use of Hologic's Adiana(R) Permanent Contraception System 2Health News:New U.K. NICE Guidance Supports Use of Hologic's Adiana(R) Permanent Contraception System 3Health News:New U.K. NICE Guidance Supports Use of Hologic's Adiana(R) Permanent Contraception System 4
(Date:5/23/2013)... 2013  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... 2013 Life Science Firm of the Year by the Tech ... honored at the TCM,s 25 th Annual Tech Awards ... Tech Awards Celebration recognizes the leaders and innovators in the ... and the surrounding regions. "We are ...
(Date:5/23/2013)... y PARÍS, 24 de mayo de 2013 /PRNewswire/ ... destacado desarrollador y fabricante de herramientas de precisión ... y tratamiento de la enfermedad vascular periférica y ... ADVISE ( Ad enosine V asodilator ... II durante la sesión de ensayo clínico hot ...
(Date:5/23/2013)... , May 23, 2013 Neurocrine Biosciences, Inc. (Nasdaq: ... Gorman , President and Chief Executive Officer of Neurocrine ... Annual dbAccess Health Care Conference in Boston.   ... at 11:20 a.m. Eastern Time / 8:20 a.m. Pacific Time.  ... the Company,s website at http://www.neurocrine.com . ...
Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... 2 "A two-year,survival rate of more ... anaplastic,astrocytoma suggests a breakthrough in this devastating ... Neuro-Oncologist and Coordinating,Investigator of the Phase IIb ... or refractory high-grade glioma, while presenting the,data ...
... American Transplant Congress in Toronto, MIAMI, June ... in,the Departments of Surgery and Pathology at the ... have corroborated the value of,monitoring cell- mediated immunity ... a regular laboratory assay of cell function,(ImmuKnow(R)/Cylex). Their ...
Cached Medicine Technology:Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 2Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 3Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 4University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients 2University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients 3University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: